Multicenter comparison of CD34+ myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?
about
Multicenter comparison of CD34+ myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Multicenter comparison of CD34 ...... stic syndrome. Is it feasible?
@en
Multicenter comparison of CD34 ...... stic syndrome. Is it feasible?
@nl
type
label
Multicenter comparison of CD34 ...... stic syndrome. Is it feasible?
@en
Multicenter comparison of CD34 ...... stic syndrome. Is it feasible?
@nl
prefLabel
Multicenter comparison of CD34 ...... stic syndrome. Is it feasible?
@en
Multicenter comparison of CD34 ...... stic syndrome. Is it feasible?
@nl
P2093
P2860
P50
P356
P1476
Multicenter comparison of CD34 ...... stic syndrome. Is it feasible?
@en
P2093
Celina Benavente
Dolores Subirá
Marta Morado
María Teresa Cedena
Patricia Font
P2860
P304
P356
10.1002/CYTO.B.21538
P577
2017-07-06T00:00:00Z